Qian; Ding-Quan
Patent Applications and Registrations
Patent applications and USPTO patent grants for Qian; Ding-Quan.The latest application filed is for "heterocyclic compounds as immunomodulators".
Company Profile
33.41.76
- Qian; Ding-Quan - Newark DE
Patent Activity
| Patent | Date |
|---|---|
| Heterocyclic Compounds As Immunomodulators App 20220194931 - Wu; Liangxing ; et al. | 2022-06-23 |
| Heterocyclic compounds as immunomodulators Grant 11,339,149 - Wu , et al. May 24, 2 | 2022-05-24 |
| Imidazotriaines and imidazopyrimidines as kinase inhibitors Grant 11,261,191 - Zhuo , et al. March 1, 2 | 2022-03-01 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20220009921 - Lu; Liang ; et al. | 2022-01-13 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20210395246 - Sun; Yaping ; et al. | 2021-12-23 |
| Bipyrazole Derivatives As Jak Inhibitors App 20210238168 - Li; Yun-Long ; et al. | 2021-08-05 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 11,014,923 - Lu , et al. May 25, 2 | 2021-05-25 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20210139485 - Wang; Xiaozhao ; et al. | 2021-05-13 |
| Bipyrazole derivatives as JAK inhibitors Grant 11,001,571 - Li , et al. May 11, 2 | 2021-05-11 |
| Bicyclic Amines As Cdk2 Inhibitors App 20210107901 - Ye; Yingda ; et al. | 2021-04-15 |
| Heterocyclic Compounds As Immunomodulators App 20210107900 - Wu; Liangxing ; et al. | 2021-04-15 |
| Bicyclic heterocycles as FGFR inhibitors Grant 10,947,230 - Sun , et al. March 16, 2 | 2021-03-16 |
| Cyclopropylamines As Lsd1 Inhibitors App 20210032244 - Wu; Liangxing ; et al. | 2021-02-04 |
| Cyclopropylamines As Lsd1 Inhibitors App 20210024487 - Wu; Liangxing ; et al. | 2021-01-28 |
| Pyrazolyl Pyrimidinylamine Compounds As Cdk2 Inhibitors App 20210017156 - Hummel; Joshua ; et al. | 2021-01-21 |
| Heterocyclic Compounds As Immunomodulators App 20210017164 - Lu; Liang ; et al. | 2021-01-21 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20200399267 - Lu; Liang ; et al. | 2020-12-24 |
| Immunomodulator Compounds And Methods Of Use App 20200397893 - Liu; Phillip C. ; et al. | 2020-12-24 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20200377504 - Wu; Liangxing ; et al. | 2020-12-03 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,851,105 - Wu , et al. December 1, 2 | 2020-12-01 |
| Immunomodulator compounds and methods of use Grant 10,806,785 - Lu , et al. October 20, 2 | 2020-10-20 |
| Heterocyclic compounds as immunomodulators Grant 10,800,768 - Wu , et al. October 13, 2 | 2020-10-13 |
| Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors App 20200317680 - Zhuo; Jincong ; et al. | 2020-10-08 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,738,048 - Lu , et al. A | 2020-08-11 |
| Imidazotriaines and imidazopyrimidines as kinase inhibitors Grant 10,738,052 - Zhuo , et al. A | 2020-08-11 |
| Cyclopropylamines As Lsd1 Inhibitors App 20200181077 - Wu; Liangxing ; et al. | 2020-06-11 |
| Heterocyclic Compounds As Immunomodulators App 20200181126 - Lu; Liang ; et al. | 2020-06-11 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20200095244 - Sun; Yaping ; et al. | 2020-03-26 |
| Bipyrazole Derivatives As Jak Inhibitors App 20200010456 - Li; Yun-Long ; et al. | 2020-01-09 |
| Cyclopropylamines as LSD1 inhibitors Grant 10,513,493 - Wu , et al. Dec | 2019-12-24 |
| Bipyrazole derivatives as JAK inhibitors Grant 10,435,392 - Li , et al. O | 2019-10-08 |
| Imidazopyrimidines And Triazolopyrimidines As A2a / A2b Inhibitors App 20190292188 - Wang; Xiaozhao ; et al. | 2019-09-26 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190284187 - Wu; Liangxing ; et al. | 2019-09-19 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20190241560 - Lu; Liang ; et al. | 2019-08-08 |
| Heterocyclic Compounds As Immunomodulators App 20190225601 - Wu; Liangxing ; et al. | 2019-07-25 |
| Cyclopropylamines As Lsd1 Inhibitors App 20190211014 - Wu; Liangxing ; et al. | 2019-07-11 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20190127376 - Wu; Liangxing ; et al. | 2019-05-02 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20190062327 - Sun; Yaping ; et al. | 2019-02-28 |
| Cyclopropylamines As Lsd1 Inhibitors App 20190062301 - Wu; Liangxing ; et al. | 2019-02-28 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 10,214,528 - Lu , et al. Feb | 2019-02-26 |
| Bipyrazole Derivatives As Jak Inhibitors App 20180312492 - Li; Yun-Long ; et al. | 2018-11-01 |
| Imidazotriaines and Imidazopyrimidines as Kinase Inhibitors App 20180282340 - Zhuo; Jincong ; et al. | 2018-10-04 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20180244672 - Lu; Liang ; et al. | 2018-08-30 |
| Heterocyclic Compounds As Immunomodulators App 20180177784 - Wu; Liangxing ; et al. | 2018-06-28 |
| Heterocyclic Compounds As Immunomodulators App 20180179197 - Wu; Liangxing ; et al. | 2018-06-28 |
| Immunomodulator Compounds And Methods Of Use App 20180177870 - Liu; Phillip C. ; et al. | 2018-06-28 |
| Amido compounds and their use as pharmaceuticals Grant 9,957,229 - Yao , et al. May 1, 2 | 2018-05-01 |
| Imidazotriazines and imidazopyrimidines as kinase inhibitors Grant 9,944,645 - Zhuo , et al. April 17, 2 | 2018-04-17 |
| Bicyclic heterocycles as FGFR4 inhibitors Grant 9,890,156 - Lu , et al. February 13, 2 | 2018-02-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170342070 - Wu; Liangxing ; et al. | 2017-11-30 |
| Heterocyclic Compounds As Immunomodulators App 20170342060 - Lu; Liang ; et al. | 2017-11-30 |
| Amido Compounds And Their Use As Pharmaceuticals App 20170334847 - Yao; Wenqing ; et al. | 2017-11-23 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20170320877 - Wu; Liangxing ; et al. | 2017-11-09 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20170166564 - Sun; Yaping ; et al. | 2017-06-15 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170158633 - Wu; Liangxing ; et al. | 2017-06-08 |
| Amido compounds and their use as pharmaceuticals Grant 9,670,154 - Yao , et al. June 6, 2 | 2017-06-06 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20170137424 - Wu; Liangxing ; et al. | 2017-05-18 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170121302 - Wu; Liangxing ; et al. | 2017-05-04 |
| Cyclopropylamines As Lsd1 Inhibitors App 20170112816 - Wu; Liangxing ; et al. | 2017-04-27 |
| Bicyclic heterocycles as FGFR inhibitors Grant 9,533,984 - Sun , et al. January 3, 2 | 2017-01-03 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,527,835 - Wu , et al. December 27, 2 | 2016-12-27 |
| Cyclopropylamines as LSD1 inhibitors Grant 9,493,450 - Wu , et al. November 15, 2 | 2016-11-15 |
| Imidazotriazines And Imidazopyrimidines As Kinase Inhibitors App 20160326178 - Zhuo; Jincong ; et al. | 2016-11-10 |
| Bipyrazole Derivatives As Jak Inhibitors App 20160289215 - Li; Yun-Long ; et al. | 2016-10-06 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160244448 - Lu; Liang ; et al. | 2016-08-25 |
| Bipyrazole derivatives as JAK inhibitors Grant 9,382,231 - Li , et al. July 5, 2 | 2016-07-05 |
| Bicyclic Heterocycles As Fgfr4 Inhibitors App 20160115164 - Wu; Liangxing ; et al. | 2016-04-28 |
| Fused pyrazoles as FGFR inhibitors Grant 9,266,892 - Zhuo , et al. February 23, 2 | 2016-02-23 |
| Amido Compounds And Their Use As Pharmaceuticals App 20150329561 - Yao; Wenqing ; et al. | 2015-11-19 |
| Amido compounds and their use as pharmaceuticals Grant 9,126,927 - Yao , et al. September 8, 2 | 2015-09-08 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225375 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225394 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225401 - Wu; Liangxing ; et al. | 2015-08-13 |
| Cyclopropylamines As Lsd1 Inhibitors App 20150225379 - Wu; Liangxing ; et al. | 2015-08-13 |
| Bipyrazole Derivatives As Jak Inhibitors App 20140343030 - Li; Yun-Long ; et al. | 2014-11-20 |
| Bicyclic Heterocycles As Fgfr Inhibitors App 20140315902 - Sun; Yaping ; et al. | 2014-10-23 |
| Fused Pyrazoles as FGFR Inhibitors App 20140171405 - Zhuo; Jincong ; et al. | 2014-06-19 |
| Substituted Tricyclic Compounds As Fgfr Inhibitors App 20130338134 - Wu; Liangxing ; et al. | 2013-12-19 |
| Substituted Heterocylic Compounds App 20130296327 - Zhuo; Jincong ; et al. | 2013-11-07 |
| Lactam compounds and their use as pharmaceuticals Grant 8,563,570 - Yao , et al. October 22, 2 | 2013-10-22 |
| Substituted Heterocyclic Compounds App 20130244999 - Zhang; Colin ; et al. | 2013-09-19 |
| Substituted heterocyclic compounds Grant 8,481,732 - Zhuo , et al. July 9, 2 | 2013-07-09 |
| Imidazotriazines and imidazopyrimidines as kinase inhibitors Grant 8,461,330 - Zhuo , et al. June 11, 2 | 2013-06-11 |
| Substituted heterocyclic compounds Grant 8,436,008 - Zhang , et al. May 7, 2 | 2013-05-07 |
| Lactam compounds and methods of using the same Grant 8,193,207 - Zhuo , et al. June 5, 2 | 2012-06-05 |
| Lactam Compounds And Their Use As Pharmaceuticals App 20120122858 - Yao; Wenqing ; et al. | 2012-05-17 |
| Triazolotriazines as kinase inhibitors Grant 8,143,251 - Zhuo , et al. March 27, 2 | 2012-03-27 |
| Lactam compounds and their use as pharmaceuticals Grant 8,110,581 - Yao , et al. February 7, 2 | 2012-02-07 |
| Amido Compounds And Their Use As Pharmaceuticals App 20120015928 - Yao; Wenqing ; et al. | 2012-01-19 |
| Amido compounds and their use as pharmaceuticals Grant 8,058,288 - Yao , et al. November 15, 2 | 2011-11-15 |
| Triazolotriazines As Kinase Inhibitors App 20110144113 - Zhuo; Jincong ; et al. | 2011-06-16 |
| Imidazotriazines And Imidazopyrimidines As Kinase Inhibitors App 20110136781 - ZHUO; Jincong ; et al. | 2011-06-09 |
| Triazolotriazines as kinase inhibitors Grant 7,915,408 - Zhuo , et al. March 29, 2 | 2011-03-29 |
| Amido Compounds And Their Use As Pharmaceuticals App 20100256114 - Yao; Wenqing ; et al. | 2010-10-07 |
| Substituted Heterocyclic Compounds App 20100240671 - ZHUO; Jincong ; et al. | 2010-09-23 |
| Amido compounds and their use as pharmaceuticals Grant 7,776,874 - Yao , et al. August 17, 2 | 2010-08-17 |
| Imidazotriazines and imidazopyrimidines as kinase inhibitors Grant 7,767,675 - Zhuo , et al. August 3, 2 | 2010-08-03 |
| Substituted Heterocyclic Compounds App 20100173901 - Zhang; Colin ; et al. | 2010-07-08 |
| Triazolotriazines As Kinase Inhibitors App 20100130467 - Zhuo; Jincong ; et al. | 2010-05-27 |
| Triazolotriazines as kinase inhibitors Grant 7,683,060 - Zhuo , et al. March 23, 2 | 2010-03-23 |
| Lactam Compounds And Their Use As Pharmaceuticals App 20090291946 - Yao; Wenqing ; et al. | 2009-11-26 |
| Amido Compounds And Their Use As Pharmaceuticals App 20080255154 - Yao; Wenqing ; et al. | 2008-10-16 |
| Imidazotriazines And Imidazopyrimidines As Kinase Inhibitors App 20080167287 - Zhuo; Jincong ; et al. | 2008-07-10 |
| Triazolotriazines As Kinase Inhibitors App 20080039457 - Zhuo; Jincong ; et al. | 2008-02-14 |
| Amido compounds and their use as pharmaceuticals Grant 7,304,081 - Yao , et al. December 4, 2 | 2007-12-04 |
| Amido compounds and their use as pharmaceuticals App 20070179142 - Yao; Wenqing ; et al. | 2007-08-02 |
| Lactam compounds and methods of using the same App 20070129345 - Zhuo; Jincong ; et al. | 2007-06-07 |
| Amido compounds and their use as pharmaceuticals App 20070066584 - Yao; Wenqing ; et al. | 2007-03-22 |
| Amido compounds and their use as pharmaceuticals App 20060122197 - Yao; Wenqing ; et al. | 2006-06-08 |
| Lactam compounds and their use as pharmaceuticals App 20060116382 - Yao; Wenqing ; et al. | 2006-06-01 |
| Amido compounds and their use as pharmaceuticals App 20050282858 - Yao, Wenqing ; et al. | 2005-12-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 